Page last updated: 2024-08-23

staurosporine and gw-5074

staurosporine has been researched along with gw-5074 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Amin, S; Jaiswal, AS; Law, BK; Narayan, S; Ramisetti, S; Sharma, AK; Singh, P; Singh-Pillay, A1
Bang, EK; El-Damasy, AK; Jin, H; Keum, G; Seo, SH1
He, S; Ji, Y; Lin, Y; Ma, H; Tian, S; Wu, S; Xia, K; Xu, C; Zhang, X; Zhu, F1

Other Studies

3 other study(ies) available for staurosporine and gw-5074

ArticleYear
ASR352, A potent anticancer agent: Synthesis, preliminary SAR, and biological activities against colorectal cancer bulk, 5-fluorouracil/oxaliplatin resistant and stem cells.
    European journal of medicinal chemistry, 2019, Jan-01, Volume: 161

    Topics: Adamantane; Antineoplastic Agents; Aza Compounds; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Fluorouracil; HCT116 Cells; HT29 Cells; Humans; Molecular Structure; Oxaliplatin; Stem Cells; Structure-Activity Relationship; Tumor Cells, Cultured

2019
Design, synthesis, and biological evaluations of novel 3-amino-4-ethynyl indazole derivatives as Bcr-Abl kinase inhibitors with potent cellular antileukemic activity.
    European journal of medicinal chemistry, 2020, Dec-01, Volume: 207

    Topics: Amination; Antineoplastic Agents; Cell Proliferation; Drug Design; Fusion Proteins, bcr-abl; Humans; Indazoles; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Docking Simulation; Protein Kinase Inhibitors

2020
Ring closure strategy leads to potent RIPK3 inhibitors.
    European journal of medicinal chemistry, 2021, May-05, Volume: 217

    Topics: Animals; Antineoplastic Agents; Cell Death; Cell Proliferation; Cell Survival; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Hypothermia; Injections, Intravenous; Mice; Mice, Inbred C57BL; Molecular Structure; Protein Kinase Inhibitors; Receptor-Interacting Protein Serine-Threonine Kinases; Structure-Activity Relationship; Systemic Inflammatory Response Syndrome; Tumor Necrosis Factor-alpha

2021